Lilit Gevorgyan PA-C

Recommended Articles

• Primary Cold Sore Infection: What Is It?

  A primary cold sore infection is described as the first time that you are infected with the herpes simplex virus (HSV) that causes cold sores. The most common area affected is the mouth. The reason is that the moist inner skin is not resistant to the virus compared to the normal skin.Primary (or...

• Is Insomnia Genetic?

  The Genetics of InsomniaOne's DNA is not only responsible for their eye and hair color, but can also contribute to health hazards and medical issues, like insomnia. According to several studies, the often weakening and detrimental sleep disorder insomnia can be genetic and hereditary. Scientists...

• Shortness of Breath and Panic Attacks

  A panic attack is the most well-known symptom of a panic disorder. Oftentimes, panic attacks come unexpectedly and are usually accompanied by various frightening physical sensations, including hyperventilation or shortness of breath. They are sudden periods of intense fear and anxiety. Panic attacks...

• Treating Head Lice

  How does head lice spread?Head lice is an infestation in the hair and scalp by insects known as pediculosis capitis. These tiny insects most commonly affect school children, and feed on the blood of the human scalp. While they are not life-threatening, they do warrant some form of treatment. The...

• Prenatal Exposure to Fever May Lead to Autism, Study Finds

  Children with autism often see things more clearly, hear things more loudly, smell things more strongly, feel things you don't, and taste things differently. Once a highly stigmatized and rarely understood disability, autism spectrum disorder has received a wealth of attention and research over the...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...